1401708-83-5, is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met
The options may be chosen on the product page CJC-1295 DAC $82 $150Price range: $82 through $150Select options This product has multiple variants
Supplementing with liposomal glutathione may support liver function, healthy aging, exercise recovery, and immune responseespecially under high oxidative stress
Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Severe gastrointestinal issues Changes in mood and behavior Pancreatitis Liver problems Low blood sugar levels (hypoglycemia) Cardiac arrhythmias Suicidal ideation Major depressive disorder No adverse event of hypoglycemia or thyroid cancer was reported in Phase II trials, and 7% of retatrutide participants had skin sensitivity, compared to 1% on placebo, but these cases were not serious
The trial demonstrated a statistically significant and superior reduction in blood sugar by 0.83% vs placebo at 26 weeks
Individual results vary, and professional guidance ensures you receive treatments appropriate for your specific needs and medical history